Interpat

Ideas
Protected for all

New IP Study on the Value of IP for health and growth

The economic benefits of strengthening the innovation environment in South Korea.

Launch of the Interpat South Korea IP Study

June 14, 2023- June 14, 2023 -Seoul, South Korea

The biopharma Intellectual Property think tank

We’re Interpat: The biopharmaceutical think tank that supports policy makers and implementors to ensure that the ideas of the future can flourish. We do this by advocating for robust tried and tested Intellectual Property frameworks that deliver certainty and security.

Membership

We actively promote the transformational benefits of IP and its power to drive original thinking in the Life Sciences. We do this with our members, governments, intergovernmental bodies, NGOs and wider society and we work tirelessly to advocate for healthcare innovation around the world

Sharing expertise

Cross-industry support

Sustainable innovation

Supporting leaders

Reviewing best practice

Ideas incubator

The Role of IP in the Biopharmaceutical

FTI Consulting were commissioned by Interpat and IFPMA to conduct the attached study following the response to Covid-19

Mexico study

Interpat and AMIIF asked Charles River Associates (CRA) to identify and quantify the economic benefits from strengthening the environment for innovation in Mexico.

Our members

Our members are some of the world’s leading biopharmaceutical companies, committed to finding innovative ways to design and deliver products that meet global healthcare challenges.